1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Global Chronic Idiopathic Constipation (CIC) Drugs Market
2.2. Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Drug Type, 2023 (US$ Million)
2.3. Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Prescription Type, 2023 (US$ Million)
2.4. Global Global Chronic Idiopathic Constipation (CIC) Drugs Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Global Chronic Idiopathic Constipation (CIC) Drugs Market Vendors
3.2. Strategies Adopted by Global Chronic Idiopathic Constipation (CIC) Drugs Market Vendors
3.3. Key Industry Strategies
4. Global Chronic Idiopathic Constipation (CIC) Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Global Chronic Idiopathic Constipation (CIC) Drugs Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Lubiprostone
5.3.2. Linaclotide

6. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Prescribed Drugs
6.3.2. Over the Counter Drugs


7. North America Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
7.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
7.4.Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
7.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
7.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
7.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)

8. UK and European Union Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.4.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.5.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.6.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)

9. Asia Pacific Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.4.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.5.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.6.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)

10. Latin America Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
10.4.Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)

11. Middle East and Africa Global Chronic Idiopathic Constipation (CIC) Drugs Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.3. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
11.4.Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.4.1.1.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.4.1.2.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.4.1.3.2. Global Chronic Idiopathic Constipation (CIC) Drugs Market: By Prescription Type, 2022-2032, USD (Million)

12. Company Profile
12.1. Actavis
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Chugai Pharmaceutical
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Ferring International Center S.A.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Synergy Pharmaceuticals
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Pfizer
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. GlaxoSmithKline
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Roche Holding AG
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Sanofi
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Bayer AG
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Salix Pharmaceuticals Ltd
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Sucampo Pharmaceuticals Inc
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Ironwood Pharmaceuticals inc
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Progenics pharmaceuticals inc
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives